...
首页> 外文期刊>Dhaka University Journal of Pharmaceutical Sciences >Development and Validation of RP-HPLC Method for Analysis of Rabeprazole Sodium
【24h】

Development and Validation of RP-HPLC Method for Analysis of Rabeprazole Sodium

机译:RP-HPLC法测定雷贝拉唑钠的建立与验证

获取原文
           

摘要

Rabeprazole sodium, a 4-(3-methoxypropoxy)-3-methylpyridinyl derivative of timoprazole, is a protonpump inhibitor that is used for the treatment of acid-peptic diseases, such as duodenal, gastric andesophageal ulceration. 1,2 A simple, decisive andresponsive reverse phase liquid chromatography (RP-HPLC) method was developed and validated forassaying rabeprazole sodium. The main purpose ofthe present study was to establish a relatively simple,single step and inexpensive HPLC method for thedetermination of rabeprazole sodium in tablet dosageform, since most of the previous methods have beenfound to be relatively complicated and expensive.This proposed method has been validated as per ICHguidelines. 3 The developed method has been found tobe rapid and sensitive which can be used to determinethe potency of rabeprazole sodium in bulk andpharmaceutical dosage form.
机译:雷贝拉唑钠是替莫拉唑的4-(3-甲氧基丙氧基)-3-甲基吡啶基衍生物,是一种质子泵抑制剂,用于治疗酸消化性疾病,例如十二指肠,胃和食管溃疡。 1,2建立了一种简单,决定性且反应灵敏的反相液相色谱(RP-HPLC)方法,并验证了该方法可用于测定雷贝拉唑钠。本研究的主要目的是建立一种测定片剂剂型中雷贝拉唑钠的相对简单,单步且廉价的HPLC方法,因为已发现大多数先前方法相对复杂且昂贵。该方法被验证为按照ICHguidelines。 3已发现开发的方法快速,灵敏,可用于测定雷贝拉唑钠在散装和药物剂型中的效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号